Creative Planning acquired a new stake in CryoPort Inc (NASDAQ:CYRX) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 602,570 shares of the consumer goods maker’s stock, valued at approximately $5,176,000. Creative Planning owned approximately 2.36% of CryoPort at the end of the most recent reporting period.
Several other institutional investors have also bought and sold shares of CYRX. Northern Trust Corp boosted its stake in CryoPort by 105.0% during the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after buying an additional 11,358 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in CryoPort in the third quarter valued at $118,000. Bank of Montreal Can purchased a new stake in CryoPort in the fourth quarter valued at $142,000. Wolverine Trading LLC purchased a new stake in CryoPort in the third quarter valued at $230,000. Finally, Granite Investment Partners LLC purchased a new stake in CryoPort in the third quarter valued at $535,000. Institutional investors and hedge funds own 20.22% of the company’s stock.
Shares of CryoPort Inc (CYRX) traded up $0.09 during midday trading on Friday, reaching $7.86. The company’s stock had a trading volume of 52,769 shares, compared to its average volume of 114,904. CryoPort Inc has a 12 month low of $1.96 and a 12 month high of $10.40. The stock has a market cap of $223.27, a P/E ratio of -15.41 and a beta of 0.72.
Separately, Roth Capital assumed coverage on CryoPort in a research report on Thursday, November 30th. They issued a “buy” rating and a $12.50 target price on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $33.50.
TRADEMARK VIOLATION WARNING: “602,570 Shares in CryoPort Inc (CYRX) Acquired by Creative Planning” was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://ledgergazette.com/2018/02/12/creative-planning-takes-5-18-million-position-in-cryoport-inc-cyrx.html.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.